Pierre Åman Selected Research

Oncogene Proteins (Oncogene Protein)

1/2022	FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma.
1/2022	FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.
1/2019	FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Åman Research Topics

Disease

9	Myxoid Liposarcoma 04/2022 - 01/2016
7	Neoplasms (Cancer) 03/2022 - 10/2017
6	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 04/2016
2	Leukemia 01/2022 - 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 04/2016
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2016

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 04/2022 - 04/2016
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2016
3	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2020 - 10/2017
1	RNA (Ribonucleic Acid)IBA 04/2024
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 03/2022
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 03/2022
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2022
1	ChromatinIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2016
1	Histone Deacetylase InhibitorsIBA 04/2016

Therapy/Procedure

5	Therapeutics 03/2022 - 04/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019